Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMAVERA: Mircera in Chronic Kidney Disease
NCT01194154Phase 2Completed
- Sponsor
- Roche
- Start
- Sep 2010
- Primary completion
- Mar 2015
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of methoxy polyethylene glycol-epoetin beta in chronic kidney disease (CKD), sponsored by Roche. Started Sep 2010; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01194154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194154.